Federal Register #CMS-2026-2839

CMS Requests Comment on ASP Data Submission for Medicare Part B Drugs

This opportunity involves a request for public comment by the Centers for Medicare & Medicaid Services (CMS), under the Department of Health and Human Services, regarding the collection of Average Sales Price (ASP) data for Medicare Part B drugs and biologicals. - Government Buyer: - Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services - Products/Services Requested: - Submission of ASP data for Medicare Part B drugs and biologicals - Quantity: 1 submission - No specific part numbers or OEMs are referenced - Unique or Notable Requirements: - Public comment is sought on the necessity, utility, and burden of the information collection - Feedback is requested on ways to improve data quality, clarity, and the use of automated collection techniques - The collection supports CMS's administration of the Medicare Drug Price Negotiation Program and is governed by 42 CFR 414.800-806 - No OEMs or commercial vendors are named in the notice - No unique product requirements or purchase quantities beyond the single submission are specified

Description

The Centers for Medicare & Medicaid Services (CMS) is seeking public comments on the proposed collection of information related to the submission of Average Sales Price (ASP) data for Medicare Part B drugs and biologicals, as well as supporting regulations in 42 CFR 414.800-806. This collection is part of CMS's efforts to administer and monitor compliance with the Medicare Drug Price Negotiation Program. The notice invites comments on the burden estimates, necessity, utility, and ways to enhance the quality and clarity of the information collected. Comments are due by October 20, 2026.

View original listing